Interventional Cardiovascular Surgery

Cardiac surgery is surgery on the heart or great vessels performed by cardiac surgeons. It is often used to treat complications of ischemic heart disease (for example, with coronary artery bypass grafting) or to treat valvular heart disease from various causes. Cardiac surgeons, interventional cardiologists and imaging specialists typically work together as the Heart Team, in particular in structural heart centres of excellence. In this section, you will find a selection of content in the field of interventional vardiovascular surgery.

View the Interventional CV Surgery editorial team

Read the editorial by F. Maisano and W. Wijns

Filtered By
TOPICS

97 results

What is the optimal aortic valve choice in the younger patient: transcatheter or surgery?

29 Nov 2023 – From PCR London Valves 2023

Follow the discussion between Darren Mylotte, Kentaro Hayashida and Ole De Backer to better understand the concept of "young patients" and what it exactly implies, and analyze how best to bring these specific patients to the end of their still potentially long life, by choosing the...

What is the optimal aortic valve choice in the younger patient: transcatheter or surgery?

Key questions in tricuspid valve intervention - What can cardiologists learn from surgeons when choosing to repair or replace the tricuspid valve?

19 Nov 2023 – From PCR London Valves 2023

Watch this session to explore the latest approaches in surgical and transcatheter tricuspid valve repair and replacement. Gain insights into the influence of right ventricular dysfunction and pulmonary hypertension on post-procedural outcomes, and understand the bleeding risks linked to oral anticoagulation in patients with tricuspid valve...

Key questions in tricuspid valve intervention - What can cardiologists learn from surgeons when choosing to repair or replace the tricuspid valve?

The mortality burden of untreated aortic stenosis

14 Nov 2023

This study, based on extensive real-world data, aimed to assess mortality rates across different untreated AS severities and AS treatment rates.

Alessandro Sticchi

Reviewer

Alessandro Sticchi

Reviewer

Giulia Costa
The mortality burden of untreated aortic stenosis

Transcatheter versus surgical aortic valve replacement in patients with severe aortic stenosis and small aortic annuli: A randomized clinical trial (the VIVA Trial)

27 Oct 2023

Luis Ortega-Paz interviews Josep Rodés-Cabau on the results of the VIVA trial which he presented at TCT Congress 2023 in San Francisco.

Luis Ortega-Paz

Author

Luis Ortega-Paz
Josep Rodés-Cabau

Author

Josep Rodés-Cabau
Transcatheter versus Surgical Aortic Valve Replacement in Patients with Severe Aortic Stenosis and Small Aortic Annuli: A Randomized Clinical Trial (the VIVA Trial)

Comparison of different percutaneous revascularisation timing strategies in patients undergoing transcatheter aortic valve implantation

24 Jul 2023

The aim of the REVASC-TAVI study was to compare different PCI timing strategies in patients with AS and significant CAD undergoing TAVI.

Alessandro Beneduce

Reviewer

Alessandro Beneduce

Reviewer

Omar Alessandro Oliva
Comparison of different percutaneous revascularisation timing strategies in patients undergoing TAVI

Evolution and prognostic impact of right ventricular–pulmonary artery coupling after transcatheter aortic valve replacement

19 Jul 2023

The aim of this study was to comprehensively assess the prognostic impact of TAPSE/PASP and its longitudinal variation in AS patients undergoing TAVR.

Alessandro Beneduce

Reviewer

Alessandro Beneduce
Luca Baldetti

Reviewer

Luca Baldetti
Evolution and prognostic impact of right ventricular–pulmonary artery coupling after transcatheter aortic valve replacement

Atrial functional tricuspid regurgitation: Importance of atrial fibrillation and right atrial remodeling and prognostic significance

18 Jul 2023

- When tricuspid regurgitation “begets” tricuspid regurgitation -

Edoardo Zancanaro

Reviewer

Edoardo Zancanaro
Atrial functional tricuspid regurgitation importance of atrial fibrillation and right atrial remodeling and prognostic significance. When tricuspid regurgitation “begets” tricuspid regurgitation

Percutaneous coronary intervention vs coronary artery bypass graft surgery for left main disease in patients with and without acute coronary syndromes: a pooled analysis of 4 randomized clinical trials

05 Jul 2023

This patient-level analysis of randomized trials comparing PCI vs CABG for the treatment of low-to-intermediate CAD involving the LM confirms the absence of long-term differences in mortality between revascularization techniques, regardless of the clinical presentation.

Giovanni Occhipinti

Reviewer

Giovanni Occhipinti
Daniele Giacoppo

Reviewer

Daniele Giacoppo
PCI vs CABG surgery for LM disease in patients with and without ACS: a pooled analysis of 4 randomized clinical trials

Outcomes of transcatheter aortic valve replacement in patients with cardiogenic shock

03 Jul 2023

This is the largest real world observational data that confirms the safety and efficacy of TAVR for the treatment of patients with severe aortic stenosis presenting with cardiogenic shock. 

Dr. Mirvat Alasnag

Reviewer

Mirvat Alasnag
Hady Lichaa

Reviewer

Hady Lichaa
Outcomes of transcatheter aortic valve replacement in patients with cardiogenic shock

PCI or CABG for left main coronary artery disease: the SWEDEHEART registry

28 Jun 2023

While the choice between PCI and CABG for LMCA disease continues to be one of the most controversial topics, patient characteristics & comorbidities must be taken into account, as must the external validity of the results of RCTs in the real world, as the SWEDEHEART registry does.

Panagiotis Xaplanteris

Reviewer

Panagiotis Xaplanteris

Reviewer

Leonidas Koliastasis
PCI or CABG for left main coronary artery disease: the SWEDEHEART registry